Jonathan Fontenot, MD
Orthopaedic Surgery · Longview, TXNPI 1275500811
Payments from drug & device makers
Across 73 payments — averaging $1126.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Precision Spine, Inc.$80K
- Spine Wave, Inc.$1K
- Stryker$262
- Life Spine, Inc.$241
- Orthofix Medical, Inc.$100
- Abbott$86
- plus $633 from 16 others
What the payments were for
- Royalty or licence$38,16746%
- Consulting fees$42,20951%
- Food & beverage$1,8412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Precision Spine, Inc. | 15 | $79,877 |
| Spine Wave, Inc. | 17 | $1,019 |
| Stryker | 6 | $262 |
| Life Spine, Inc. | 3 | $241 |
| Orthofix Medical, Inc. | 2 | $100 |
| Abbott | 3 | $86 |
| Medtronic(2 entities) | 5 | $80 |
| Providence Medical Technology, Inc. | 2 | $78 |
| Alafair Biosciences, Inc. | 2 | $64 |
| Pfizer | 2 | $60 |
| Smith+Nephew | 1 | $48 |
| Amgen | 3 | $47 |
| Johnson & Johnson | 3 | $44 |
| Pylant Medical | 1 | $42 |
| Olympus America Inc. | 1 | $32 |
| Avanos Medical | 1 | $29 |
| Zimmer Biomet | 1 | $23 |
| Cerapedics Inc. | 1 | $23 |
| AbbVie | 1 | $18 |
| Forte Bio-pharma LLC | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Saluda Medical Americas, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reform Modular$67,375
- Reform Pedicle Screw System$12,502
- EXCEED BIPLANAR EXPANDABLE INTERBODY SYSTEM$500
- ARx$118
- MAKO$117
How this compares
$82,218 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 169 | $2,191 |
| Celecoxib | 48 | $1,636 |
| Methocarbamol | 79 | $849 |
| Tizanidine Hcl | 83 | $802 |
| Gabapentin | 67 | $626 |
| Pregabalin | 27 | $465 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 46 | $413 |
| Tramadol Hcl | 30 | $213 |
| Methylprednisolone | 35 | $210 |
| Cyclobenzaprine Hcl | 19 | $177 |
| Meloxicam | 34 | $168 |
| Duloxetine Hcl | 11 | $150 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Longview
- Babajide OgunseindeLongview$670K
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- J Richard EvansonPlano$8.1M
- Stefan KreuzerHouston$7M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Howard HarrisBedford$4.6M
- Tiffany HuynhHouston$4.6M
- Michael WirthSan Antonio$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.